Lazaros J Lekakis MD

Oncology•Miami, FL

Assistant Professor, Medicine, University of Miami Leonard M. Miller School of Medicine

Join to View Full Profile

1475 Nw 12th AveSuite 3300 (D8-4)Miami, FL 33136
Phone+1 305-748-0641

Education & Training

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1999 - 2002
University of AthensClass of 1995

Certifications & Licensure

FL State Medical License 2010 - 2027
KY State Medical License 2006 - 2011
IL State Medical License 1999 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease Start of enrollment: 2012 Mar 01
Completed
Phase 2
Axicabtagene Ciloleucel Expanded Access Study
Approved for marketing
STRIDE Biorepository Start of enrollment: 2017 Mar 13
Recruiting
Roles: Contact
A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL) Start of enrollment: 2021 Nov 12
Active, not recruiting
Phase 2
Roles: Principal Investigator
A Study to Investigate LYL797 in Adults With Solid Tumors Start of enrollment: 2022 Mar 29
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Contact
Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults with Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2) Start of enrollment: 2020 May 21
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Itacitinib for the Prevention of IEC Therapy-Associated CRS: Results From the Two-Part Phase 2 INCB 39110-211 Study.
Matthew J Frigault, Richard T Maziarz, Jae H Park, Aleksandr Lazaryan, Nirav N Shah
Blood. 2025-03-16
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.
Mark C Walters, Mary Eapen, Yiwen Liu, Fuad El Rassi, Edmund K Waller
Blood Advances. 2025-03-11
Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study.
Mohamed A Kharfan-Dabaja, Razan Mohty, Neela Easwar, Patrick Johnston, Madiha Iqbal
Bone Marrow Transplantation. 2025-03-01

Abstracts/Posters

CD19-Loss with Preservation of Other B Cell Lineage Features in Patients with Large B Cell Lymphoma Who Relapsed Post_Axi-Cel
Lazaros J. Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...
Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Comparison of Two-Year Outcomes in ZUMA-1 (Axicabtagene Ciloleucel) and SCHOLAR-1 in Patients with Refractory Large B Cell Lymphoma
Lazaros J Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium
Lazaros J. Lekakis, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Join now to see all

Lectures

Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other Languages

Greek